PAK1 and PAK2 have different roles in HGF-induced morphological responses

被引:34
|
作者
Bright, Michael D. [1 ]
Garner, Andrew P. [2 ]
Ridley, Anne J. [1 ]
机构
[1] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England
[2] AstraZeneca, Canc & Infect Res Area, Macclesfield SK10 4TG, Cheshire, England
基金
英国生物技术与生命科学研究理事会;
关键词
PAK; HGF; Cell migration; Prostate cancer cells; Cell-cell junctions; Rho GTPases; HEPATOCYTE GROWTH-FACTOR; PROSTATE-CANCER CELLS; P21-ACTIVATED KINASE; THERAPEUTIC INHIBITION; C-MET; ACTIVATION; ACTIN; FAMILY; PIX; INVASION;
D O I
10.1016/j.cellsig.2009.07.005
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Hepatocyte growth factor (HGF) stimulates dissociation of epithelial cells (scattering) and cell migration. Several Rho GTPases are required for HGF-induced scattering. PAK1 and PAK2 are members of the p21-activated kinase (PAK) family of serine/threonine kinases, and are activated by the Rho GTPases Rac and Cdc42. Here we investigate the contributions of PAK1 and PAK2 to HGF-induced motile response. HGF stimulates phosphorylation of PAK1 and PAK2. Knockdown of PAK1 inhibits HGF-stimulated migration and loss of cell-cell junctions in DU145 prostate carcinoma cells, whereas knockdown of PAK2 enhances loss of cell-cell junctions and increases lamellipodium extension but does not affect migration speed. On the other hand, in PC3 prostate carcinoma cells, which lack cell-cell junctions, knockdown of PAK1 or PAK2 reduces HGF-stimulated migration. PAK2 knockdown increases phosphorylation of PAKI, indicating that PAK2 provides a negative feedback on PAK1. We hypothesise that PAK2 acts in part via PAKI to regulate HGF-induced scattering. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:1738 / 1747
页数:10
相关论文
共 50 条
  • [1] Different roles for PAK1 and PAK2 in the interaction of leukemia cells with fibronectin
    Kuzelova, K.
    Grebenova, D.
    Obr, A.
    Roselova, P.
    Holoubek, A.
    [J]. FEBS JOURNAL, 2017, 284 : 354 - 355
  • [2] PAK1, PAK1Δ15, and PAK2: similarities, differences and mutual interactions
    Dana Grebeňová
    Aleš Holoubek
    Pavla Röselová
    Adam Obr
    Barbora Brodská
    Kateřina Kuželová
    [J]. Scientific Reports, 9
  • [3] PAK1, PAK1Δ15, and PAK2: similarities, differences and mutual interactions
    Grebenova, Dana
    Holoubek, Ales
    Roselova, Pavla
    Obr, Adam
    Brodska, Barbora
    Kuzelova, Katerina
    [J]. SCIENTIFIC REPORTS, 2019, 9 (1)
  • [4] PAK1 and PAK2 in cell metabolism regulation
    Koranova, Tereza
    Dvoracek, Lukas
    Grebenova, Dana
    Roselova, Pavla
    Obr, Adam
    Kuzelova, Katerina
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2022, 123 (02) : 375 - 389
  • [5] Expression of PAK1 and PAK2 Is Associated With Grade of Pulmonary Neuroendocrine Tumors
    Smith, Stephen
    Bissonnette, Adam
    Cohen, David
    Timmers, Cynthia
    Jen, Jin
    Fukuoka, Junya
    Franks, Teri
    Travis, William
    Carbone, David
    Shilo, Konstantin
    [J]. LABORATORY INVESTIGATION, 2015, 95 : 490A - 490A
  • [6] PAK1 and PAK2 kinases play a role in epithelial to mesenchymal transition
    O'Connor, Matthew
    Shaaban, Salam
    Mulford, Iain
    Pachter, Jonathan
    Kan, Julie
    [J]. CANCER RESEARCH, 2009, 69
  • [7] Expression of PAK1 and PAK2 Is Associated With Grade of Pulmonary Neuroendocrine Tumors
    Smith, Stephen
    Bissonnette, Adam
    Cohen, David
    Timmers, Cynthia
    Jen, Jin
    Fukuoka, Junya
    Franks, Teri
    Travis, William
    Carbone, David
    Shilo, Konstantin
    [J]. MODERN PATHOLOGY, 2015, 28 : 490A - 490A
  • [8] Expansion of BCR/ABL1+ cells requires PAK2 but not PAK1
    Edlinger, Leo
    Berger-Becvar, Angelika
    Menzl, Ingeborg
    Hoermann, Gregor
    Greiner, Georg
    Grundschober, Eva
    Bago-Horvath, Zsuzsanna
    Al-Zoughbi, Wael
    Hoefler, Gerald
    Brostjan, Christine
    Gille, Lars
    Moriggl, Richard
    Spittler, Andreas
    Sexl, Veronika
    Hoelbl-Kovacic, Andrea
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2017, 179 (02) : 229 - 241
  • [9] MAINTENANCE OF LEUKAEMOGENIC POTENTIAL OF BCR/ABL plus CELLS REQUIRES PAK2 BUT NOT PAK1
    Hoelbl-Kovacic, A.
    Berger, A.
    Edlinger, L.
    Menzl, I.
    Hoermann, G.
    Grundschober, E.
    Bago-Horvath, Z.
    Sexl, V.
    [J]. HAEMATOLOGICA, 2017, 102 : 430 - 430
  • [10] Pak1 and Pak2 mediate tumor cell invasion through distinct signaling mechanisms
    Coniglio, Salvatore J.
    Zavarella, Salvatore
    Symons, Marc H.
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2008, 28 (12) : 4162 - 4172